Cann Group doubles sales as CBD use takes off
Medicinal cannabis grower and manufacturer Cann Group has seen sales more than double in the past year as the use of cannabinoid products take off in Australia. The company, which owns a GMP approved production facility at Mildura, Victoria (pictured), said sales revenue for the 12 months to June 2023 was an unaudited $13.5 million,…